Skip to main content

ALTERACIONES EN LA FUNCION DE LA CELULA ALFA PANCREATICA Y EN LA SECRECION DE GLUCAGON: CONTRIBUCION A LA HIPERGLICEMIA Y A LA DIABETES TIPO 1 Y 2.

BFU2013-42789-P

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D (Excelencia / Generación de Conocimiento)
Call year 2013
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre UNIVERSIDAD MIGUEL HERNANDEZ DE ELCHE

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

RUA. Repositorio Institucional de la Universidad de Alicante
Publication Otros (Other)

Effects of Bisphenol A on ion channels: Experimental evidence and molecular mechanisms

  • Soriano, Sergi
  • Ripoll, Cristina
  • Alonso Magdalena, Paloma
  • Fuentes, Esther
  • Quesada, Iván
  • Nadal, Ángel
  • Martinez-Pinna, Juan
  • Martinez-Pinna, Juan|||/items/17fe7946-bb18-45cf-bd71-482acc1cec7b
  • Soriano, Sergi|||/items/8e3d590c-5b30-415a-93aa-bf5d4506efe4
Bisphenol A (BPA) is an endocrine-disrupting chemical (EDC) produced in huge quantities in the manufacture of polycarbonate plastics and epoxy resins. It is present in most humans in developed countries, acting as a xenoestrogen and it is considered an environmental risk factor associated to several diseases. Among the whole array of identified mechanisms by which BPA can interfere with physiological processes in living organisms, changes on ion channel activity is one of the most poorly understood. There is still little evidence about BPA regulation of ion channel expression and function. However, this information is key to understand how BPA disrupts excitable and non-excitable cells, including neurons, endocrine cells and muscle cells. This report is the result of a comprehensive literature review on the effects of BPA on ion channels. We conclude that there is evidence to say that these important molecules may be key end-points for EDCs acting as xenoestrogens. However, more research on channel-mediated BPA effects is needed. Particularly, mechanistic studies to unravel the pathophysiological actions of BPA on ion channels at environmentally relevant doses.
RUA. Repositorio Institucional de la Universidad de Alicante
Publication Otros (Other)

Extranuclear-initiated estrogenic actions of endocrine disrupting chemicals: Is there toxicology beyond paracelsus?

  • Nadal, Ángel
  • Fuentes, Esther
  • Ripoll, Cristina
  • Villar-Pazos, Sabrina
  • Castellano-Muñoz, Manuel
  • Soriano, Sergi
  • Martinez-Pinna, Juan
  • Quesada, Iván
  • Alonso Magdalena, Paloma
  • Martinez-Pinna, Juan|||/items/17fe7946-bb18-45cf-bd71-482acc1cec7b
  • Soriano, Sergi|||/items/8e3d590c-5b30-415a-93aa-bf5d4506efe4
Endocrine Disrupting Chemicals (EDCs), including bisphenol-A (BPA) do not act as traditional toxic chemicals inducing massive cell damage or death in an unspecific manner. EDCs can work upon binding to hormone receptors, acting as agonists, antagonists or modulators. Bisphenol-A displays estrogenic activity and, for many years it has been classified as a weak estrogen, based on the classic transcriptional action of estrogen receptors serving as transcription factors. However, during the last two decades our knowledge about estrogen signaling has advanced considerably. It is now accepted that estrogen receptors ERα and ERβ activate signaling pathways outside the nucleus which may or may not involve transcription. In addition, a new membrane estrogen receptor, GPER, has been proposed. Pharmacological and molecular evidence, along with results obtained in genetically modified mice, demonstrated that BPA, and its substitute BPS, are potent estrogens acting at nanomolar concentrations via extranuclear ERα, ERβ, and GPER. The different signaling pathways activated by BPA and BPS explain the well-known estrogenic effects of low doses of EDCs as well as non-monotonic dose-response relationships. These signaling pathways may help to explain the actions of EDCs with estrogenic activity in the etiology of different pathologies, including type-2 diabetes and obesity.
RUA. Repositorio Institucional de la Universidad de Alicante
Publication Otros (Other)

Molecular mechanisms involved in the non-monotonic effect of bisphenol-a on ca2+ entry in mouse pancreatic β-cells

  • Villar-Pazos, Sabrina
  • Martinez-Pinna, Juan
  • Castellano-Muñoz, Manuel
  • Alonso Magdalena, Paloma
  • Marroquí, Laura
  • Quesada, Iván
  • Gustafsson, Jan-Ake
  • Nadal, Ángel
  • Martinez-Pinna, Juan|||/items/17fe7946-bb18-45cf-bd71-482acc1cec7b
In regulatory toxicology, the dose-response relationship is a key element towards fulfilling safety assessments and satisfying regulatory authorities. Conventionally, the larger the dose, the greater the response, following the dogma “the dose makes the poison”. Many endocrine disrupting chemicals, including bisphenol-A (BPA), induce non-monotonic dose response (NMDR) relationships, which are unconventional and have tremendous implications in risk assessment. Although several molecular mechanisms have been proposed to explain NMDR relationships, they are largely undemonstrated. Using mouse pancreatic β-cells from wild-type and oestrogen receptor ERβ−/− mice, we found that exposure to increasing doses of BPA affected Ca2+ entry in an NMDR manner. Low doses decreased plasma membrane Ca2+ currents after downregulation of Cav2.3 ion channel expression, in a process involving ERβ. High doses decreased Ca2+ currents through an ERβ-mediated mechanism and simultaneously increased Ca2+ currents via oestrogen receptor ERα. The outcome of both molecular mechanisms explains the NMDR relationship between BPA and Ca2+ entry in β-cells.
RUA. Repositorio Institucional de la Universidad de Alicante
Publication Otros (Other)

The bile acid TUDCA increases glucose-induced insulin secretion via the cAMP/PKA pathway in pancreatic beta cells

  • Vettorazzi, Jean Franciesco
  • Ribeiro, Rosane Aparecida
  • Borck, Patricia Cristine
  • Branco, Renato Chaves Souto
  • Soriano, Sergi
  • Merino, Beatriz
  • Boschero, Antônio Carlos
  • Nadal, Ángel
  • Quesada, Iván
  • Carneiro, Everardo Magalhães
  • Soriano, Sergi|||/items/8e3d590c-5b30-415a-93aa-bf5d4506efe4
Objective. While bile acids are important for the digestion process, they also act as signaling molecules in many tissues, including the endocrine pancreas, which expresses specific bile acid receptors that regulate several cell functions. In this study, we investigated the effects of the conjugated bile acid TUDCA on glucose-stimulated insulin secretion (GSIS) from pancreatic β-cells. Methods. Pancreatic islets were isolated from 90-day-old male mice. Insulin secretion was measured by radioimmunoassay, protein phosphorylation by western blot, Ca2 + signals by fluorescence microscopy and ATP-dependent K+ (KATP) channels by electrophysiology. Results. TUDCA dose-dependently increased GSIS in fresh islets at stimulatory glucose concentrations but remained without effect at low glucose levels. This effect was not associated with changes in glucose metabolism, Ca2 + signals or KATP channel activity; however, it was lost in the presence of a cAMP competitor or a PKA inhibitor. Additionally, PKA and CREB phosphorylation were observed after 1-hour incubation with TUDCA. The potentiation of GSIS was blunted by the Gα stimulatory, G protein subunit-specific inhibitor NF449 and mimicked by the specific TGR5 agonist INT-777, pointing to the involvement of the bile acid G protein-coupled receptor TGR5. Conclusion. Our data indicate that TUDCA potentiates GSIS through the cAMP/PKA pathway.